Silent progression in disease activity-free relapsing multiple sclerosis.
null nullBruce A C CreeJill A HollenbachRiley BoveGina KirkishSimone SaccoEduardo CaverzasiAntje BischofTristan GundelAlyssa H ZhuNico PapinuttoWilliam A SternCarolyn BevanAndrew RomeoDouglas S GoodinJeffrey M GelfandJennifer GravesAri J GreenMichael R WilsonScott S ZamvilChao ZhaoRefujia GomezNicholas R RaganGillian Q RushPatrick BarbaAdam SantanielloSergio E BaranziniJorge R OksenbergRoland G HenryStephen L HauserPublished in: Annals of neurology (2019)
Long-term worsening is common in relapsing MS patients, is largely independent of relapse activity, and is associated with accelerated brain atrophy. We propose the term silent progression to describe the insidious disability that accrues in many patients who satisfy traditional criteria for relapsing-remitting MS. Ann Neurol 2019;85:653-666.
Keyphrases
- multiple sclerosis
- disease activity
- white matter
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- ankylosing spondylitis
- rheumatoid arthritis patients
- newly diagnosed
- ejection fraction
- chronic kidney disease
- juvenile idiopathic arthritis
- peritoneal dialysis
- mass spectrometry
- ms ms
- gestational age